SARS News and Research

RSS

Child mortality in England dropped significantly during COVID-19 pandemic

In a study conducted at Cardiff University and the University of Bristol, UK, scientists have observed that in England, the all-cause child mortality rate has dropped significantly during the first year of coronavirus disease 2019 (COVID-19) pandemic compared to that in the pre-pandemic year. The highest reduction in mortality rate has been observed in children under the age of 10 years. The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Study shows school closures can be minimized by regular testing and vaccination against COVID-19

A new study discusses a novel model to determine age-specific differences in susceptibility of infection, contact patterns, and contagiousness to COVID-19.

25 Aug 2021

The woman behind the development of mRNA-based vaccines against coronavirus

With her research, biochemist Katalin Karikó laid the foundation for the development of RNA vaccines against the coronavirus. Now she is being honoured for this by the Würzburg Societas Physico-Medica.

25 Aug 2021

COVID-19 hospitalizations 29 times more likely in unvaccinated individuals, CDC study suggests

Getting inoculated against SARS-CoV-2 protects against getting severe COVID-19 or being hospitalized. In a new study by the U.S. Centers for Disease Control and Prevention (CDC), scientists noted that unvaccinated individuals are 29 times more likely to be hospitalized due to COVID-19 than those who were vaccinated.

25 Aug 2021

Predictability of single symptom screening for pediatric SARS-CoV-2 infections

A new study on the preprint server medRxiv* discusses the predictive value of single symptom-based screening to confirm pediatric SARS-CoV-2 cases.

25 Aug 2021

Higher mortality rates and age-related disease patterns in pediatric COVID-19

The current study examines children in pediatric ICU (PICU) care with COVID-19. Read more here.

25 Aug 2021

Higher SARS-CoV-2 Delta variant transmission among K-12 schoolchildren can be reduced by interventions, says study

A new study reports the results of a model framed to explore the transmission of the delta variant among schoolchildren and the most effective intervention methods to minimize such spread.

25 Aug 2021

Can the spread of COVID-19 infection be mitigated through a strict vaccination strategy within 100 days?

A new study evaluates the new COVID-19 policy implemented in NSW.

25 Aug 2021

Analysis of antibody titer decay following vaccination or SARS-CoV-2 infection

A new study focused on the decrease in antibody titers following two doses of BNT162b2 vaccine or SARS-CoV-2 natural infection in Israel.

25 Aug 2021

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

A study published on medRxiv* preprint server reported the over-time changes in the ability of the serum to activate platelets in vitro.

25 Aug 2021

Unconventional T cell and inflammation levels in COVID-19 during pregnancy

A new study published on the medRxiv* preprint server has focused on investigating SARS-CoV-2 immune responses in pregnant women

25 Aug 2021

Research highlights the potential benefits of SARS-CoV-2 S gene mutants as immunogens

Previous research has shown that the spike (S) protein of -CoV-2 binds to a host cell receptor, facilitating viral entry.

25 Aug 2021

Scientists forecast healthcare burden of future COVID waves

The findings indicate that given the lower vaccine efficacy against the SARS-CoV-2 delta variant, France may face a large epidemic wave infecting 25% of the general population even with a 95% vaccine coverage. This, in turn, could affect the healthcare system in terms of hospital bed occupancy. The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Study on SARS-CoV-2 Delta breakthrough infections shows twice the risk as Alpha

A recent study conducted by Portuguese scientists has claimed that mRNA-based coronavirus disease 2019 (COVID-19) vaccines are less effective against the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Moreover, in breakthrough infections by delta variant, vaccines are less effective in reducing viral loads. The study is currently available on the medRxiv* preprint server.

25 Aug 2021

Reassuring news about the protection that SARS-CoV-2 vaccines offer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have proven effective at preventing COVID-19-related mortality and illness. Since no vaccine is 100% effective, breakthrough infections are likely to occur. New research by a group of scientists at Erasmus Medical Center and Radboud University in the Netherlands looked at vaccine-breakthrough infections in a large group of vaccinated healthcare workers (HCWs).

25 Aug 2021

SARS-CoV-2 Delta likely to acquire resistance to wild-type spike vaccines

A new study published on the preprint server bioRxiv* explores the mechanism of the Delta variant's high infectivity and suggests a plausible pathway by which the Delta variant could escape from vaccine-induced immunity.

24 Aug 2021

Compounds from medicinal mushrooms may be our future weapon against SARS-CoV-2

Certain steroid-like compounds from Taiwan's endemic medicinal mushrooms (known as antcins) may inhibit a host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, thus, prevent viral infection and subsequent development of the coronavirus disease (COVID-19), reports a new study published in the MDPI's journal Plants.

24 Aug 2021

SARS News and Research

Child mortality in England dropped significantly during COVID-19 pandemic

Study shows school closures can be minimized by regular testing and vaccination against COVID-19

The woman behind the development of mRNA-based vaccines against coronavirus

COVID-19 hospitalizations 29 times more likely in unvaccinated individuals, CDC study suggests

Predictability of single symptom screening for pediatric SARS-CoV-2 infections

Higher mortality rates and age-related disease patterns in pediatric COVID-19

Higher SARS-CoV-2 Delta variant transmission among K-12 schoolchildren can be reduced by interventions, says study

Can the spread of COVID-19 infection be mitigated through a strict vaccination strategy within 100 days?

Analysis of antibody titer decay following vaccination or SARS-CoV-2 infection

Persistence of Anti-PF4 levels in VITT patients four months after AstraZeneca COVID-19 vaccine

Unconventional T cell and inflammation levels in COVID-19 during pregnancy

Research highlights the potential benefits of SARS-CoV-2 S gene mutants as immunogens

Scientists forecast healthcare burden of future COVID waves

Study on SARS-CoV-2 Delta breakthrough infections shows twice the risk as Alpha

Reassuring news about the protection that SARS-CoV-2 vaccines offer

SARS-CoV-2 Delta likely to acquire resistance to wild-type spike vaccines

Compounds from medicinal mushrooms may be our future weapon against SARS-CoV-2

Breast milk of vaccinated mothers contains antibodies that may protect nursing infants from COVID-19

Do aerosol boxes prevent airborne spread of SARS-CoV-2?

Glycyrrhizic acid as a drug candidate for COVID-19

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News